A large-scale survey on cardio-cerebrovascular events during pitavastatin (LIVALO tablet) therapy in Japanese patients with hypercholesterolemia - LIVALO effectiveness and safety study extension (LIVES study extension)

Japanese Pharmacology and Therapeutics

Volumn 39, Issue 9, 2011, Pages 789-803

  Teramoto, Tamio ^a   Urashima, Mitsuyoshi ^b   Shimano, Hitoshi ^c   Yokote, Koutaro ^d   Saito, Yasushi ^d  

^a TEIKYO UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Cardiovascular cerebrovascular events; LIVES study extension; Pitavastatin

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PITAVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; JAPANESE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MYALGIA; PRACTICE GUIDELINE; SIDE EFFECT; SUDDEN DEATH;

EID: 80054859738     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kurihara Y, Douzono T, Kawakita K, Nagasaka Y. A large-scale, long-term, prospective post-marketing surveillance of pitavastatin (LIVALO tablet) : LIVALO effectiveness and safety (LIVES) study. Jpn Pharmacol Ther 2008; 36 (8) : 709-31.
2. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study) : a prospective randomised controlled trial. Lancet 2006; 368 (9542) : 1155-63. (Pubitemid 44444932)
3. Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease : secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J 2002; 66 (12) : 1096-100. (Pubitemid 35416313)
4. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66 (12) : 1087-95. (Pubitemid 35416312)
5. Itakura H, Nakaya N, Kusunoki T, Shimizu N, Hirai S, Mochizuki S, et al. Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia : Efficacy and incidence of cardiac and other events in elderly patients (≥65 years old). J Cardiol 2011; 57 (1) : 77-88.
6. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, et al. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int 2010; 1 : 2-20.
7. Miller WG, Myers GL, Sakurabayashi I, Bachmann LM, Caudill SP, Dziekonski A, et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem 2010; 56 (6) : 977-86.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24 (1) : 35-41. (Pubitemid 23014379)
9. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseasesIII. Stroke 1990; 21 (4) : 637-76.
10. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, et al. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14 (2) : 45-50.
11. Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, et al. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007; 190 (1) : 216-23. (Pubitemid 44908318)
12. Okamura T, Kadowaki T, Hayakawa T, Kita Y, Okayama A, Ueshima H, et al. What cause of mortality can we predict by cholesterol screening in the Japanese general population? J Intern Med 2003; 253 (2) : 169-80. (Pubitemid 36197537)
13. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350 (15) : 1495-504. (Pubitemid 38477774)
14. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352 (14) : 1425-35. (Pubitemid 40471450)
15. Teramoto T, Saito Y, Yamada N, Itakura H, Hata Y, Tsushima M, et al. Clinical safety and efficacy of NK-104 (Pitavastatin) a new synthetic HMG-CoA reductase inhibitor in the long-term treatment of hyperlipidemia : results of a multicenter long-term study. J Clin Ther Med 2001; 17 (6) : 885-913.
16. Olsson AG, Istad H, Luurila O, Ose L, Stender S, Tuomilehto J, et al. Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia. Am Heart J 2002; 144 (6) : 1044-51. (Pubitemid 36026918)
17. Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, et al. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Clin Ther 2008; 30 (6) : 1089-101. (Pubitemid 351978115)
18. Teramoto T, Shimano H, Yokote K, Urashima M. Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia. J Atheroscler Thromb 2009; 16 (5) : 654-61.
19. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Cholesterol Treatment Trialists' (CTT) Collaborators, efficacy and safety of cholesterol-lowering treatment : prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005 8 ; 366 (9493) : 1267-78.
20. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007; 357 (13) : 1301-10. (Pubitemid 47481452)
21. Jafri H, Alsheikh-Ali AA, Karas RH. Meta-analysis : statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk. Ann Intern Med 2010; 153 (12) : 800-8.